Newbridge Financial Services Group, Inc. Exelixis, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $575 Million
- Q2 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 261 shares of EXEL stock, worth $10,463. This represents 0.0% of its overall portfolio holdings.
Number of Shares
261Holding current value
$10,463% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
688Shares Held
260MCall Options Held
1.41MPut Options Held
1.55M-
Black Rock Inc. New York, NY33.5MShares$1.34 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.1 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$643 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$634 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$456 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...